Artesunate regulates malignant progression of breast cancer cells via lncRNA TUG1/miR-145-5p/HOXA5 axis

• Chao Yang ,

  Roles Conceptualization, Funding acquisition, Supervision

  * E-mail: ydsyyc@hebmu.edu.cn (CY); lyj818326@hebmu.edu.cn (YL)

  Affiliation Department of Breast Center, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China

  https://orcid.org/0009-0005-8020-5683

  ⨯
• Yunjiang Liu ,

  Roles Conceptualization, Funding acquisition

  * E-mail: ydsyyc@hebmu.edu.cn (CY); lyj818326@hebmu.edu.cn (YL)

  Affiliations Department of Breast Center, Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, China, Hebei Provincial Key Laboratory of Tumor Microenvironment and Drug Resistance, Hebei Medical University, Shijiazhuang, Hebei, China

  ⨯
• Lingyun Gai,

  Roles Investigation, Methodology, Writing – original draft

  Affiliation Department of Breast Center, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China

  ⨯
• Ziteng Zhang,

  Roles Data curation, Formal analysis

  Affiliation Department of Breast Center, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China

  ⨯
• Yanshou Zhang,

  Roles Software

  Affiliation Department of Breast Center, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China

  ⨯
• Geng Zhang,

  Roles Project administration

  Affiliation Department of Breast Center, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China

  ⨯
• Kaiye Du,

  Roles Validation, Visualization

  Affiliation Radiotherapy Department, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China

  ⨯
• Chao Gao

  Roles Validation, Visualization

  Affiliation Radiotherapy Department, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China

  ⨯